Browse Category

Future Trends News 20 October 2025 - 12 November 2025

IBM Unveils ‘Nighthawk’ & ‘Loon’ Quantum Chips: Targets 2026 Quantum Advantage and 2029 Fault Tolerance

IBM Unveils ‘Nighthawk’ & ‘Loon’ Quantum Chips: Targets 2026 Quantum Advantage and 2029 Fault Tolerance

IBM announced two new quantum processors—Nighthawk and Loon—plus major Qiskit software upgrades and a community “advantage tracker,” aiming for verified quantum advantage by 2026 and fault‑tolerant systems by 2029. Stock ticks higher on the news. What happened today At its annual Quantum Developer Conference, International Business Machines Corporation (NYSE: IBM) unveiled two headline advances for quantum computing: IBM Quantum Nighthawk, a 120‑qubit processor built to push toward near‑term quantum advantage in 2026, and IBM Quantum Loon, an experimental architecture that demonstrates all the core hardware elements needed for fault‑tolerant quantum computing on a 2029 timeline. IBM also detailed significant Qiskit
12 November 2025
Morgan Stanley: Apple Could Earn $133 Billion a Year From Humanoid Robots by 2040 — As Big as Today’s App Store

Morgan Stanley: Apple Could Earn $133 Billion a Year From Humanoid Robots by 2040 — As Big as Today’s App Store

November 7, 2025 Apple’s next multi‑billion‑dollar business may not live on a screen. A new Morgan Stanley research note making the rounds today projects that Apple could generate roughly $130–$133 billion in annual revenue from humanoid and home robotics by 2040, putting the category on par with the scale of today’s App Store and ahead of several existing hardware lines. The report—widely cited across financial and tech media—also sketches a likely first step: a tabletop, motorized home hub expected as early as 2027, paving the way for more capable robots later in the 2030s. Yahoo Finance+1 Key numbers at a glance Why Morgan Stanley
Nvidia’s Meteoric October: $4 Trillion Milestone, Mega AI Deals, and Unstoppable Momentum

Nvidia’s Jensen Huang Warns “China Is Going to Win the AI Race” — Then Urges U.S. to “Race Ahead” (Nov. 6, 2025)

Published: November 6, 2025 Summary: Nvidia CEO Jensen Huang said China is “going to win the AI race,” citing cheaper energy and lighter regulation, before clarifying in a later statement that China is only “nanoseconds behind” and that it’s “vital that America wins” by accelerating investment and growing its developer base. His remarks come amid continued U.S. curbs on advanced Nvidia chip sales to China and Beijing’s push to replace foreign AI chips. reuters.com+2axios.com+2 Key points What Huang said — and why it matters Speaking to the FT in London, Huang’s headline remark — “China is going to win the
Rivian’s Wild 2025 Ride: Stock Price Update, Q3 Surprises, EV Rivalry & Future Forecasts

Rivian’s Wild 2025 Ride: Stock Price Update, Q3 Surprises, EV Rivalry & Future Forecasts

RIVN Stock Price & Recent Performance 🚥 Rivian’s stock price as of November 5, 2025 sits around $12.50 per share. This is roughly 5% lower than the prior day’s close, due to a post-earnings pullback, but notably the stock was trading up about 6% in pre-market activity on Nov 5 – indicating some recovery. In the last few weeks, RIVN has seesawed: it rallied into the earnings report (topping $13), then sold off on the news, and is now attempting a rebound. Over the past week, shares are down ~6–7%, and over the past month roughly flat (-2.3% vs +2.1%
Beyond Meat (BYND) Stock Forecast 2025: Will Plant-Based Meat Sizzle or Fizzle?

Beyond Meat (BYND) Stock Forecast 2025: Will Plant-Based Meat Sizzle or Fizzle?

Current Stock Price and Performance As of early November 2025, Beyond Meat’s stock is trading in the mid-$1 range per share Stockanalysis. The latest closing price was about $1.39 on Nov 3, 2025 Stockanalysis, a stunning collapse from its peak of $239.71 in 2019. This means BYND has lost roughly 99% of its value since its all-time high Barchart. Even on a 52-week basis, the stock’s range has been extreme – it hit a low of about $0.50 during a capitulation in 2025 and a 52-week high around $7.69 Stockanalysis (reached back in early 2025 before the slide accelerated). The
Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outlook

Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outlook

Company Background and Business Model Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company specializing in RNA interference (RNAi) therapies for cancer. The company was co-founded by Nobel laureate Dr. Craig Mello, a discoverer of RNAi, leveraging that legacy to develop its proprietary INTASYL™ gene-silencing technologyphiopharma.com. Originally known as RXi Pharmaceuticals (founded ~2011), Phio rebranded and refocused on immuno-oncology. Its mission is to use small interfering RNA (siRNA) to “silence” genes that allow tumors to evade the immune system, thereby empowering the body’s own defenses to fight cancerragingbull.com. Headquartered in Pennsylvania (King of Prussia) with R&D roots in Massachusetts, Phio is
Virgin Galactic’s Wild 2025 Ride: Space Tourism Liftoff, Stock Surges & Cash Burn – What’s Next for SPCE?

Virgin Galactic’s Wild 2025 Ride: Space Tourism Liftoff, Stock Surges & Cash Burn – What’s Next for SPCE?

SPCE Stock Turbulence: October Rally and Crash Landing Virgin Galactic’s stock price has been on a wild ride in 2025. After a long downward drift to multi-year lows, SPCE suddenly surged in early October 2025, fueled by a flurry of upbeat headlines. The stock leapt from about $3.42 on Oct. 1 to $4.89 by Oct. 16 – a >40% jump in two weeks ts2.tech. On Oct. 16 alone it popped 6%, reflecting renewed optimism as traders piled in on the space-tourism news cycle. This burst of speculative buying briefly lifted SPCE out of its slump (though notably still “well under
ChatGPT Crashes Worldwide — Downdetector Alarms, OpenAI Responds, Markets React

OpenAI’s Half-Trillion Restructuring Hands Microsoft a $135 B Stake – and Revs Up the ‘AGI Arms Race’

OpenAI Restructures at $500 B: Nonprofit Control Meets For-Profit Ambition In a milestone moment for the AI industry, OpenAI has officially restructured itself to unite a half-trillion-dollar for-profit business with its original nonprofit mission. The company announced on Oct. 28 that it “completed its recapitalization, simplifying its corporate structure”, with the nonprofit arm retaining control over the newly created OpenAI Group PBC (Public Benefit Corporation)openai.comeconomictimes.indiatimes.com. Under this novel setup, the OpenAI Foundation (nonprofit) holds a 26% stake valued around $130 billion and can appoint all board directors, effectively steering the shipmedium.commedium.com. Meanwhile, investors and employees own roughly 47%, and Microsoft holds 27% after
Meet Neo: The $20K Humanoid Butler Coming to Your Home (With a Big Catch!)

Meet Neo: The $20K Humanoid Butler Coming to Your Home (With a Big Catch!)

With its launch on Oct 28, Neo has become a symbol of both promise and reality in home robotics. It embodies the cutting edge of AI and mechanical engineering – and a hint of sci-fi-level convenience – but it also underscores how far we have to go. As 1X’s CEO and robotics experts alike note, Neo will improve over time through data and software updates, but for now early adopters are effectively helping to train the robot. In the words of one expert, Neo is a “bold glimpse of our robot-assisted future” – exciting, but not yet the household Rosie
Joby Aviation Stock Skyrockets on Game-Changing Deals & FAA Push (Oct 2025)

Joby Aviation Stock Hits Turbulence After 200% Rally – Will the Air Taxi Dream Take Off or Crash?

A Wild Week for JOBY Stock Joby Aviation’s stock price has been on a wild ride in recent days, reflecting both the sky-high optimism and the jitters surrounding this futuristic air-taxi company. On Tuesday, Oct. 28, Joby’s shares closed at $15.60, down about 4.3% for the dayinvesting.com. The dip caps off a volatile week: just last Monday (Oct. 20) the stock spiked 11% in a single day, then plunged a combined ~12% over the next two sessionsinvesting.com. Even with the recent pullback, Joby’s stock is still dramatically higher than where it began the year – up roughly 97% year-to-date as
Brightline’s Next Stops: Cocoa & Vegas – Will High‑Speed Rail Boom or Bust?

Brightline’s Next Stops: Cocoa & Vegas – Will High‑Speed Rail Boom or Bust?

Florida’s Space Coast Station: Funding Hopes Rise Local officials on Florida’s Space Coast are betting big on Brightline. After a setback in 2024 – when the Federal Railroad Administration rejected Cocoa’s $47.46 million grant request for a station – the community has rallied to try againel-balad.com. At an October 14 Brevard County Commission meeting, Commissioner Thad Altman relayed encouraging news: staff at the SCTPO (Space Coast TPO) believe the new federal funding round gives Cocoa a much stronger shot at successel-balad.com. The federal government has earmarked $5 billion for rail projects nationwide, meaning Brightline’s Cocoa stop could secure a share of that
1 2 3 4 5 9

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Go toTop